A deformability-based biochip for precise label-free stratification of metastatic subtypes using deep learning
- khoobeeluan
- Feb 17
- 2 min read
This paper presents the development of a novel parallel constriction-based microfluidic flow cytometry device coupled with an integrated computational framework, termed ATMQcD, aimed at measuring cellular deformability as a biomarker for assessing cell physiological states. The ATMQcD framework streamlines the analysis process by incorporating automatic training set generation, multiple object tracking, segmentation, and quantification of cellular deformability. Validation with various cancer cell lines demonstrated a high classification accuracy of 92.4% for assessing invasiveness and effectively stratifying cells pre- and post-hypoxia treatment. The system also distinguished cancer cells from leukocytes with an accuracy of 89.5%. A power-law rheology model was developed to quantify stiffness, allowing for the evaluation of metastatic potential across different cancer types and mixed cell populations under realistic clinical conditions. This robust computational framework enhances the scalability of microfluidic assays, positioning it as a promising tool for high-throughput cellular analysis in clinical applications.
For more info, DOI: 10.1038/s41378-023-00577-1

Komentar